SCHEMBL29844533

SCHEMBL29844533

COc1ccc(CNc2nccc3cc(C#N)c(OC)cc23)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
PDE5A O76074 2/20 0.51
KDM4E B2RXH2 4/20 0.50
ALDH1A1 P00352 3/20 0.50
HPGD P15428 2/20 0.50
PDE3B Q13370 2/20 0.48
PDE3A Q14432 2/20 0.48
PDE10A Q9Y233 2/20 0.48
TNF P01375 1/20 0.48
POLB P06746 3/20 0.47
DYRK1A Q13627 1/20 0.46
CLK4 Q9HAZ1 1/20 0.46
MAPT P10636 2/20 0.45
BLM P54132 1/20 0.45
WNT3A P56704 2/20 0.45
NPC1 O15118 1/20 0.45
EGFR P00533 1/20 0.45
NR2F2 P24468 1/20 0.45
HTT P42858 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23529687 1.00 MEN1 (0.54) MEN1KMT2APDE5AKDM4EALDH1A1
SCHEMBL15820514 0.86 NPC1 (0.47) MEN1KMT2APDE5AKDM4EALDH1A1
SCHEMBL29844513 0.81 MEN1 (0.55) MEN1KMT2APDE5AKDM4EALDH1A1
SCHEMBL23560586 0.81 MEN1 (0.55) MEN1KMT2APDE5AKDM4EALDH1A1
SCHEMBL29929742 0.77 WNT3A (0.43) PDE5AKDM4EALDH1A1HPGDPOLB
SCHEMBL28631850 0.77 WNT3A (0.43) PDE5AKDM4EALDH1A1HPGDPOLB
SCHEMBL1715696 0.76 NPC1 (0.58) PDE5AKDM4EALDH1A1HPGDPOLB
SCHEMBL18300154 0.76 HTT (0.52) MEN1KMT2APDE5APOLBDYRK1A
SCHEMBL27201465 0.75 MEN1 (0.53) MEN1KMT2APDE5APOLBDYRK1A
SCHEMBL509566 0.74 EGFR (0.64) MEN1KMT2AKDM4EPOLBCLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113004284-B Tetracyclic compounds as plasma kallikrein inhibitors and uses thereof 成都康弘药业集团股份有限公司 2022-08-12 CN disclosed
CN-113004286-B Tricyclic compounds as plasma kallikrein inhibitors and uses thereof 成都康弘药业集团股份有限公司 2022-08-12 CN disclosed